AI Radiology AI Specialist
An AI Radiology AI Specialist bridges clinical radiology and deep-learning engineering to build, validate, deploy, and continuousl…
Skill Guide
The rigorous quantitative assessment of a diagnostic AI model's performance across key metrics (sensitivity, specificity, AUROC), its probabilistic accuracy (calibration), and its equitable performance across patient subgroups (subgroup fairness).
Scenario
You are given predictions (probabilities and binary labels) from a chest X-ray model for detecting pneumonia on a validation set of 1000 images.
Scenario
Evaluate a diabetic retinopathy screening AI model on a test set that includes patient metadata (age group, sex, and ethnicity).
Scenario
Prepare the statistical evaluation section for a 510(k) or De Novo submission for a novel AI-based sepsis prediction system to the FDA.
Core computational tools for calculating metrics, performing statistical tests, and creating reproducible analysis notebooks. BI tools are used for creating stakeholder-friendly performance dashboards.
Methodological frameworks for robust performance estimation, assessing probabilistic accuracy, evaluating equity, and quantifying clinical utility, respectively.
Structured templates and regulatory guidance for transparently documenting model performance, limitations, and fairness, which are essential for internal review and external submissions.
Answer Strategy
Test for miscalibration and poor performance at the operational threshold. Response: 'A high AUROC indicates good ranking ability but doesn't guarantee well-calibrated probabilities or useful performance at a specific decision threshold. I would first examine the calibration plot; a significant deviation from the diagonal suggests over- or under-confidence in predicted probabilities. Second, I'd analyze the PR curve and the precision-recall trade-off at the operating point the clinicians would use, as poor precision (high false positive rate) could lead to alert fatigue. I would also conduct a subgroup analysis to ensure the high AUROC isn't masking poor performance in a key patient population.'
Answer Strategy
Demonstrate nuanced understanding of fairness trade-offs and business risk. Response: 'The question of fairness is not binary and depends on the chosen metric and context. Here, we have a violation of the 'Equalized Odds' fairness criterion, meaning the model's error rates are not consistent across groups. While the overall AUROC is strong, this disparity presents a significant clinical and reputational risk. We must first rule out data quality or representation issues in that subgroup. If the disparity persists, we face a strategic choice: 1) Accept the model with enhanced monitoring and targeted post-processing for that subgroup, 2) Retrain with fairness-aware algorithms or adjusted loss functions, or 3) Redefine the clinical pathway to ensure augmented human oversight for that demographic. The decision hinges on our risk tolerance and commitment to equitable care.'
1 career found
Try a different search term.